Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population

Hypertension Research

Volumn 30, Issue 11, 2007, Pages 1129-1137

  Niu, Wenquan ^a   Qi, Yue ^a   Cen, Weijun ^b   Cui, Chaoying ^b   Zhuoma, Ciren ^b   Cai, Dan ^b   Zhou, Wenyu ^a   Qiu, Changchun ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b People's Hospital of Tibet Autonomous Region   (China)

Author keywords

Angiotensinogen; Epistasis; Essential hypertension; Haplotype; Single locus

Indexed keywords

ADENINE; ANGIOTENSINOGEN; GUANINE; THYMINE;

ACCURACY; ADULT; ALLELE; ARTICLE; CHINA; COMPUTER PROGRAM; CONTROLLED STUDY; DATA MINING; EPISTASIS; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEQUENCE ANALYSIS; VALIDATION STUDY;

ADULT; AGED; ANGIOTENSINOGEN; EPISTASIS, GENETIC; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TIBET;

EID: 37849007933     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.1129     Document Type: Article

References (45)

1. Lifton RP, Dluhy RG, Powers M, et al: A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262-265.
2. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
3. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M: Prediction of genetic risk for hypertension. Hypertension 2003; 41: 1035-1040.
4. Kiyomoto H, Hitomi H: The earlier, the better. Hypertens Res 2007; 30: 1-2.
5. Gaillard I, Clauser E, Corvol P: Structure of human angiotensinogen gene. DNA 1989; 8: 87-99.
6. Gaillard-Sanchez I, Mattei MG, Clauser E, Corvol P: Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene. Hum Genet 1990; 84: 341-343.
7. Smithies O, Kim HS: Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci U S A 1994; 91: 3612-3615.
8. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
9. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM: Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: 1331-1337.
10. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y: Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens 1999; 17: 757-763.
11. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R: M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9-17.
12. Newton-Cheh C, Hirschhorn JN: Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005; 573: 54-69.
13. Moore JH, Williams SM: New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002; 34: 88-95.
14. Culverhouse R, Klein T, Shannon W: Detecting epistatic interactions contributing to quantitative traits. Genet Epidemiol 2004; 27: 141-152.
15. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95: 948-953.
16. Gesang L, Liu G, Cen W, et al: Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res 2002; 25: 481-485.
17. Liu Y, Zhuoma C, Shan G, et al: A1166C polymorphism of the angiotensin II type I receptor gene and essential hypertension in Han, Tibetan and Yi populations. Hypertens Res 2002; 25: 515-521.
18. Velez DR, Guruju M, Vinukonda G, Prater A, Kumar A, Williams SM: Angiotensinogen promoter sequence variants in essential hypertension. Am J Hypertens 2006; 19: 1278-1285.
19. Zapata C, Carollo C, Rodriguez S: Sampling variance and distribution of the D′ measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet 2001; 65: 395-406.
20. Ritchie MD, Hahn LW, Moore JH: Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003; 24: 150-157.
21. Moore JH: The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003; 56: 73-82.
22. Kim HS, Krege JH, Kluckman KD, et al: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92: 2735-2739.
23. Caulfield M, Lavender P, Farrall M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-1633.
24. Caulfield M, Lavender P, Newell-Price J, et al: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96: 687-692.
25. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J: M235←T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens 1996; 14: 1061-1065.
26. Moore JH: A global view of epistasis. Nat Genet 2005; 37: 13-14.
27. Williams SM, Addy JH, Phillips JA, et al: Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000; 36: 2-6.
28. Tsai CT, Fallin D, Chiang FT, et al: Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003; 41: 9-15.
29. Kamitani A, Rakugi H, Higaki J, et al: Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994; 8: 521-524.
30. Chiang FT, Hsu KL, Tseng CD, et al: Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997; 15: 607-611.
31. Cheung BM, Leung R, Shiu S, Tan KC, Lau CP, Kumana CR: M235T polymorphism of the angiotensinogen gene and hypertension in Chinese. J Hypertens 1998; 16: 1137-1140.
32. Rotimi C, Morrison L, Cooper R, et al: Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994; 24: 591-594.
33. Morise T, Takeuchi Y, Takeda R: Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med 1995; 237: 175-180.
34. Corvol P, Jeunemaitre X: Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 1997; 18: 662-677.
35. Tamaki S, Nakamura Y, Tabara Y, et al: Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample: the Shigaraki Study. Hypertens Res 2005; 28: 645-650.
36. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921-927.
37. Gu CC, Chang YP, Hunt SC, et al: Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. Hum Hered 2005; 60: 164-176.
38. Nakajima T, Wooding S, Sakagami T, et al: Natural selection and population history in the human angiotensinogen gene (AG7): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74: 898-916.
39. Nakajima T, Jorde LB, Ishigami T, et al: Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 2002; 70: 108-123.
40. Moore JH, Ritchie MD: The challenges of whole-genome approaches to common diseases. JAMA 2004; 291: 1642-1643.
41. Martin ER, Ritchie MD, Hahn L, Kang S, Moore JH: A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet Epidemiol 2006; 30: 111-123.
42. Millstein J, Conti DV, Gilliland FD, Gauderman WJ: A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006; 78: 15-27.
43. Andrew AS, Nelson HH, Kelsey KT, et al: Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2006; 27: 1030-1037.
44. Sanada H, Yatabe J, Midorikawa S, et al: Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52: 352-360.
45. Lizanecz E, Pasztor ET, Mohacsi A, Papp Z, Edes I, Toth A: Mistyping of angiotensinogen M235T alleles. Hypertens Res 2006; 29: 197-201.